UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Industry involvement in clinical practice guidelines

Canadian family physician, 2021-10, Vol.67 (10), p.721-724

Lexchin, Joel R.

2021

Volltextzugriff (PDF)

Formula choices in infants with cow's milk allergy

Canadian family physician, 2021-05, Vol.67 (5), p.318-319

Lexchin, Joel R

2021

Volltextzugriff (PDF)

Cost-of-living challenges highlight urgency for clinicians to prescribe affordable medications

Canadian family physician, 2023-09, Vol.69 (9), p.599-600

2023

Volltextzugriff (PDF)

Les défis du coût de la vie soulignent l’urgence pour les médecins de prescrire des médicaments abordables

Canadian family physician, 2023-09, Vol.69 (9), p.606-608

2023

Volltextzugriff (PDF)

Les défis du coût de la vie soulignent l’urgence pour les médecins de prescrire des médicaments abordables

Canadian family physician, 2023-09, Vol.69 (9), p.606

2023

Volltextzugriff (PDF)

Pharmaceuticals as a market for “lemons”: Theory and practice

Social science & medicine (1982), 2021-01, Vol.268, p.113368, Article 113368

2021

Volltextzugriff (PDF)

Pharmaceutical research and development: what do we get for all that money?

BMJ (Online), 2012-08, Vol.345 (aug07 1), p.e4348-e4348

2012

Volltextzugriff (PDF)

Engaging physicians to prescribe more cost-effectively: Blueprint for change

Canadian family physician, 2020-10, Vol.66 (10), p.723-725

2020

Volltextzugriff (PDF)

The term cognition-enhancing medications is misleading

Canadian family physician, 2018-11, Vol.64 (11), p.792-792

Lexchin, Joel R

2018

Volltextzugriff (PDF)

Inciter les médecins à prescrire en se souciant davantage des coûts: Stratégie de changement

Canadian family physician, 2020-10, Vol.66 (10), p.e251-e254

2020

Volltextzugriff (PDF)

Can reporting of adverse drug reactions create safer systems while improving health data?

Canadian Medical Association journal (CMAJ), 2015-08, Vol.187 (11), p.789-790

2015

Volltextzugriff (PDF)

Composition of Canadian Pain Society guideline development group?

Canadian family physician, 2018-01, Vol.64 (1), p.8-8

Lexchin, Joel R

2018

Volltextzugriff (PDF)

Antidepressants are not safe during pregnancy and in women of child‐bearing age

British journal of clinical pharmacology, 2022-05, Vol.88 (5), p.2447-2448

2022

Volltextzugriff (PDF)

The Need to Systematically Evaluate Clinical Practice Guidelines

Journal of the American Board of Family Medicine, 2016-11, Vol.29 (6), p.644-648

2016

Volltextzugriff (PDF)

Conflicts of Interest and the Presence of Methodologists on Guideline Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major Depressive Disorder

Psychotherapy and psychosomatics, 2017-01, Vol.86 (3), p.168-170

2017

Volltextzugriff (PDF)

Implications of pharmaceutical industry funding on clinical research

The Annals of pharmacotherapy, 2005-01, Vol.39 (1), p.194-197

Lexchin, Joel R

2005

Volltextzugriff (PDF)

From caveat emptor to caveat venditor: time to stop the influence of money on practice guideline development

Journal of evaluation in clinical practice, 2014-12, Vol.20 (6), p.809-812

2014

Volltextzugriff (PDF)

Canadian family physician Medecin de famille canadien

Canadian family physician, 2020-10, Vol.66 (10), p.e251-e254

2020

Volltextzugriff (PDF)

Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles

PLoS medicine, 2011-03, Vol.8 (3), p.e1000425

2011

Volltextzugriff (PDF)

Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review

PLoS medicine, 2010-10, Vol.7 (10), p.e1000352-e1000352

2010

Volltextzugriff (PDF)

Developing a Clinician Friendly Tool to Identify Useful Clinical Practice Guidelines: G-TRUST

Annals of family medicine, 2017-09, Vol.15 (5), p.413-418

2017

Volltextzugriff (PDF)

Variation in the prescription drugs covered by health systems across high-income countries: A review of and recommendations for the academic literature

Health policy (Amsterdam), 2020-03, Vol.124 (3), p.231-238

2020

Volltextzugriff (PDF)

How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA

Canadian Medical Association journal, 2003-09, Vol.169 (5), p.405

2003

Volltextzugriff (PDF)

Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis

BMJ quality & safety, 2022-03, Vol.31 (3), p.179-190

2022

Volltextzugriff (PDF)

Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study

Drug safety, 2022-06, Vol.45 (6), p.623-638

2022

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(44)
Bücher
(1)

Sprache

Englisch
(43)
Französisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Industry involvement in clinical practice guidelines

Formula choices in infants with cow's milk allergy

Cost-of-living challenges highlight urgency for clinicians to prescribe affordable medications

Les défis du coût de la vie soulignent l’urgence pour les médecins de prescrire des médicaments abordables

Les défis du coût de la vie soulignent l’urgence pour les médecins de prescrire des médicaments abordables

Pharmaceuticals as a market for “lemons”: Theory and practice

Pharmaceutical research and development: what do we get for all that money?

Engaging physicians to prescribe more cost-effectively: Blueprint for change

The term cognition-enhancing medications is misleading

Inciter les médecins à prescrire en se souciant davantage des coûts: Stratégie de changement

Can reporting of adverse drug reactions create safer systems while improving health data?

Composition of Canadian Pain Society guideline development group?

Antidepressants are not safe during pregnancy and in women of child‐bearing age

The Need to Systematically Evaluate Clinical Practice Guidelines

Conflicts of Interest and the Presence of Methodologists on Guideline Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major Depressive Disorder

Implications of pharmaceutical industry funding on clinical research

From caveat emptor to caveat venditor: time to stop the influence of money on practice guideline development

Canadian family physician Medecin de famille canadien

Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles

Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review

Developing a Clinician Friendly Tool to Identify Useful Clinical Practice Guidelines: G-TRUST

Variation in the prescription drugs covered by health systems across high-income countries: A review of and recommendations for the academic literature

How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA

Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis

Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study

Suchergebnisse filtern